- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07337954
3D-CT vs Ellipsoid for JJ Stent Prediction Before ESWL
Estimation of Critical Stone Burden Requiring JJ Stent Before Extracorporeal Shockwave Lithotripsy Using 3D-CT
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This prospective single-center study at Ain Shams University evaluates 3D-CT volumetry versus traditional ellipsoid formula for predicting critical stone burden requiring preoperative JJ stent placement in patients undergoing ESWL for 1-2 cm renal stones. Eligible patients (target n=56) with single radio-opaque renal stones will receive two ESWL sessions using Dornier lithotripter without initial stenting. Stone characteristics will be assessed via non-contrast CT (NCCT): linear dimensions (ellipsoid formula: length×width×height×0.52), 3D volume (automated voxel-based segmentation), Hounsfield units, and skin-to-stone distance.
Patients will be stratified by ESWL outcomes: stone clearance without stenting versus those requiring JJ stent due to complications (infection, incomplete fragmentation, obstruction/Stein Strasse). Volume measurements will be compared between groups using appropriate statistical tests (t-test, ROC analysis). The study aims to establish a 3D-CT volume threshold for stent prediction and validate its superiority over ellipsoid formula, particularly for irregular stone morphology.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Cairo Governorate
-
Cairo, Cairo Governorate, Egypt, 1151
- Faculty of Medicine, Ain Shams University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Age 18-65 years
- BMI 18-30 kg/m²
- Single radio-opaque renal stone 1-2 cm
- Suitable for ESWL per clinical assessment
Exclusion Criteria:
- Multiple renal stones
- Solitary kidney
- Impaired renal function
- Congenital renal anomalies
- Ureteric obstruction
- Systemic comorbidities
- Pregnancy
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: ESWL without Initial JJ Stent
All 56 patients received standardized ESWL treatment using third-generation Dornier lithotripter (maximum 2 sessions, 2500 shock waves/session).
No preoperative JJ stent placement.
Stone volume assessed via dual methods: 3D-CT volumetry (voxel-based segmentation) and ellipsoid formula (greatest dimensions on NCCT).
Follow-up at 2 weeks with KUB/ultrasound; JJ stent placed for complications (incomplete fragmentation, obstruction, Stein Strasse, infection)
|
ESWL delivered at 70-80 shocks/min, max 2500 shocks/session, voltage ramped to 90 kV.
Stone localization via fluoroscopy.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Stone Volume by 3D-CT Volumetry
Time Frame: Pre-ESWL baseline
|
Comparison of stone volume measured by 3D-CT volumetry (voxel-based segmentation, cm³) versus traditional ellipsoid formula (greatest dimensions method) to determine critical stone burden predicting JJ stent necessity after ESWL.
ROC analysis identified optimal cutoff (>1.88 cm³) for stent requirement
|
Pre-ESWL baseline
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
JJ Stent Necessity
Time Frame: 2 weeks post-ESWL
|
Rate of JJ stent placement due to ESWL complications (incomplete fragmentation, obstruction, Stein Strasse, infection)
|
2 weeks post-ESWL
|
|
ESWL Success Rate
Time Frame: 2 weeks after maximum 2 ESWL sessions
|
Stone-free rate (complete clearance or asymptomatic fragments <4mm on KUB/ultrasound)
|
2 weeks after maximum 2 ESWL sessions
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- FMASU MS872024
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Urolithiasis
-
Beni-Suef UniversityRecruiting
-
Singapore General HospitalUnknown
-
Kırıkkale UniversityCompletedKidney Calculi Nephrolithiasis Urolithiasis Renal Stone
-
University of Sao Paulo General HospitalCompletedUrolithiasis and Aging | Renal Calcul and Metabolic Diseases | Urolithiasis and OsteoporosisBrazil
-
EULIS Colloborative Research Working GroupUnknownKidney Calculi | Nephrolithiasis | Patient Compliance | Calcium Oxalate Urolithiasis
-
Catalysis SLCompletedKidney Calculi | Kidney Injury | Urolithiasis | Ureteral Calculi | Ureteral Obstruction | Renal Disease | Renal Stone | Ureteral Injury | Renal Injury | Urolithiasis, Calcium Oxalate | Urolithiasis; Lower Urinary TractNicaragua
-
University of Alabama at BirminghamNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); University...RecruitingHealthy | Kidney Calculi | Nephrolithiasis | Urolithiasis | Kidney Stone | Nephrolithiasis, Calcium Oxalate | Oxaluria | Urolithiasis, Calcium Oxalate | Oxalate UrolithiasisUnited States
-
London Health Sciences Centre Research Institute...St. Joseph's Health Care LondonCompletedKidney Calculi | Nephrolithiasis | Kidney Stone | Human | Calcium Oxalate Urolithiasis | Vitamin K 2 | Calcium Oxalate Kidney Stones | Calcium Phosphate UrolithiasisCanada
-
University of Alabama at BirminghamNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); University...RecruitingHealthy | Kidney Calculi | Nephrolithiasis | Urolithiasis | Healthy Volunteer | Kidney Stones | Nephrolithiasis, Calcium Oxalate | Urolithiasis, Calcium Oxalate | Oxalate UrolithiasisUnited States
-
University of Alabama at BirminghamNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); University...RecruitingKidney Calculi | Nephrolithiasis | Urolithiasis | Kidney Stone | Nephrolithiasis, Calcium Oxalate | Oxaluria | Urolithiasis, Calcium Oxalate | Oxalate UrolithiasisUnited States
Clinical Trials on Extracorporeal shock wave lithotripter
-
Yuzuncu Yıl UniversityCompleted
-
Isfahan University of Medical SciencesUnknownPlantar FasciitisIran, Islamic Republic of
-
Yonsei UniversityUnknownPost-Stroke Elbow SpasticityKorea, Republic of
-
South Valley UniversityRecruitingShock Wave and Nitric OxideEgypt
-
Carol Davila University of Medicine and PharmacyCompletedStroke, Ischemic | Stroke Hemorrhagic | Balance; Distorted | Spasticity as Sequela of Stroke | Spastic GaitRomania
-
Saglik Bilimleri UniversitesiEnrolling by invitationStroke | Spasticity as Sequela of StrokeTurkey
-
Şeyhmus KAPLANCompletedPain | Lateral EpicondylitisTurkey
-
Chimei Medical CenterUnknownCalcific TendinitisTaiwan
-
Technical University of MunichWithdrawn
-
Tri-Service General HospitalWithdrawnCarpal Tunnel SyndromeTaiwan